Mirum Pharmaceuticals Inc (MIRM)

Jun 17, 2025

Rhumbline Advisers Purchases 2,321 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

Jun 17, 2025

Jun 15, 2025

Where are the Opportunities in (MIRM) - news.stocktradersdaily.com

Jun 15, 2025

Jun 14, 2025

Insider Sell: William Fairey Sells Shares of Mirum Pharmaceutica - GuruFocus

Jun 14, 2025

Jun 12, 2025

High Growth Tech Stocks In The US Market - Yahoo Finance

Jun 12, 2025

Jun 12, 2025

Cantor Fitzgerald Predicts MIRM FY2026 Earnings - Defense World

Jun 12, 2025

Jun 10, 2025

Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan

Jun 10, 2025

Jun 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo

Jun 10, 2025

Jun 08, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 08, 2025

Jun 06, 2025

Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025

Jun 06, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.06 Million Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

Jun 06, 2025

Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharm - GuruFocus

Jun 04, 2025

Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 - Investing.com Australia

Jun 04, 2025

Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharmaceuticals Inc (MIRM) - GuruFocus

Jun 04, 2025

Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 03, 2025

(MIRM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 03, 2025

May 31, 2025

Mirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth - MSN

May 31, 2025

May 30, 2025

Mirum Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

May 30, 2025

May 30, 2025

Alagille Syndrome Treatment Market Detailed in New Research ReportMirum Pharmaceuticals, Albireo Pharma - openPR.com

May 30, 2025

May 29, 2025

Two Sigma Investments LP Has $5.23 Million Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

May 29, 2025

May 28, 2025

Man Group plc Invests $289,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 28, 2025

May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential By Investing.com - Investing.com South Africa

May 26, 2025

May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential - Investing.com Nigeria

May 26, 2025

May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 26, 2025

May 23, 2025

When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com

May 23, 2025

May 22, 2025

Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Changes - Defense World

May 22, 2025

May 22, 2025

What is HC Wainwright’s Estimate for MIRM Q2 Earnings? - Defense World

May 22, 2025

May 21, 2025

Mirum Pharmaceuticals at RBC Conference: Strategic Growth Highlights - Investing.com

May 21, 2025

May 20, 2025

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - citybiz

May 20, 2025

May 20, 2025

Comerica Bank Reduces Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 20, 2025

May 20, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025

May 19, 2025

Mirum Pharmaceuticals Names Doug Sheehy New Chief Legal Officer - Bloomberg Law News

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwri - GuruFocus

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Appoints New Chief Legal Officer | - GuruFocus

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwright & Co. | MIRM Stock News - GuruFocus

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating with Promising Growth Potential | MIRM Stock News - GuruFocus

May 19, 2025

May 17, 2025

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $60.64 - Defense World

May 17, 2025

May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025

May 15, 2025

Northern Trust Corp Acquires 32,059 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 15, 2025

May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 15, 2025

May 14, 2025

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

May 14, 2025

May 13, 2025

Mirum Pharmaceuticals (MIRM) Maintains Strong Buy Rating with Ra - GuruFocus

May 13, 2025

May 13, 2025

Mirum Pharmaceuticals (MIRM) Gets Price Target Boost to $77 | MI - GuruFocus

May 13, 2025

May 13, 2025

Trend Tracker for (MIRM) - news.stocktradersdaily.com

May 13, 2025

May 12, 2025

FY2025 EPS Estimates for MIRM Raised by Cantor Fitzgerald - Defense World

May 12, 2025

May 12, 2025

Leerink Partnrs Brokers Increase Earnings Estimates for MIRM - Defense World

May 12, 2025

May 11, 2025

JMP Securities Increases Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $76.00 - Defense World

May 11, 2025

May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Stron - GuruFocus

May 09, 2025

May 09, 2025

Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock - Benzinga

May 09, 2025

May 09, 2025

Mirum Pharmaceuticals (MIRM) Maintains Market Outperform Rating with Higher Price Target | MIRM Stock News - GuruFocus

May 09, 2025